BioCentury
ARTICLE | Company News

Globe Laboratories, National Pharmaceuticals deal

March 28, 2011 7:00 AM UTC

CRO Globe Laboratories granted National Pharmaceuticals exclusive, worldwide rights to GLB333. The partners plan to start Phase I/II testing of GLB333, which is an undisclosed cytokine inhibitor, to t...